Climb Bio Inc.
CLYM | NASDAQ
$10.24
-$0.09 (-0.87%)
At close: Oct 30, 2026, 3:59 PM ET
$10.25
+$0.01 (+0.10%)
Pre-market:
Nov 2, 2026, 4:36 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.55 | -1.18 | -6.02 | -4.55 | -1.85 | -3.97 |
PEG Ratio | 0.11 | -0.07 | 0.25 | 0.08 | -0.02 | -0.02 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.69 | 0.41 | 1.96 | 1.60 | 0.57 | 4.23 |
P/FCF Ratio | -4.97 | -5.57 | -10.26 | -5.51 | -2.66 | -6.48 |
P/OCF Ratio | -4.99 | -5.57 | -10.26 | -5.51 | -2.66 | -6.48 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0 | n/a | n/a |
Quick Ratio | 15.16 | 31.41 | 38.92 | 22.04 | 24.58 | 7.18 |
Current Ratio | 15.16 | 31.41 | 38.92 | 22.04 | 24.58 | 7.18 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -37.30% | -34.88% | -32.64% | -35.15% | -28.40% | -95.83% |
Return on Assets | -35.68% | -34.02% | -31.79% | -33.52% | -27.41% | -83.91% |
Return on Invested Capital | -42.16% | -38.61% | -37.30% | -34.94% | -21.33% | -97.02% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CLYM